| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/096120339600500103 |
| P698 | PubMed publication ID | 8646228 |
| P50 | author | Robert G. Lahita | Q56860707 |
| Joan T Merrill | Q67485131 | ||
| P2860 | cites work | Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells | Q28588469 |
| Role for intracellular proteases in the processing and transport of class II HLA antigens | Q33578498 | ||
| Regulation of endocytic pH by the Na+,K+-ATPase in living cells | Q33831627 | ||
| Isolation and characterization of the intracellular MHC class II compartment. | Q34340778 | ||
| Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents | Q34556950 | ||
| Toward an understanding of the molecular mechanisms of physiological cell death. | Q36073702 | ||
| Induction of tolerance to autoimmune diabetes with islet antigens | Q36231852 | ||
| Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells | Q36275163 | ||
| Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells | Q36350981 | ||
| Regulation of antigen presentation by acidic pH. | Q36351024 | ||
| Inhibition of DNA and RNA polymerase reactions by chloroquine | Q36378101 | ||
| The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire | Q36676063 | ||
| Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules | Q37478507 | ||
| Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells | Q38328072 | ||
| Antimalarials in the management of discoid and systemic lupus erythematosus | Q39772563 | ||
| Antigen-Presenting Function of the Macrophage | Q40119147 | ||
| Determinant spreading and the dynamics of the autoimmune T-cell repertoire. | Q40487702 | ||
| Signals and signs for lymphocyte responses | Q40620206 | ||
| Prevention of diabetes in BB/Wor rats by intrathymic islet injection | Q41018994 | ||
| Immunosuppressive potential of antimalarials | Q41585528 | ||
| Invariant chain influences the immunological recognition of MHC class II molecules | Q41734417 | ||
| Lysosomes, pH and the Anti-malarial Action of Chloroquine | Q41935841 | ||
| A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus | Q41942545 | ||
| Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis | Q41945100 | ||
| Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro | Q44274859 | ||
| Intracellular transport of class II MHC molecules directed by invariant chain. | Q45941447 | ||
| Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways | Q46424023 | ||
| Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes | Q46512140 | ||
| Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. | Q55066037 | ||
| Making class II presentable | Q58444266 | ||
| Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes | Q59098594 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 6-10 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation? | |
| P478 | volume | 5 |
| Q44175614 | A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice |
| Q34604474 | Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit |
| Q34129797 | Antimalarials. |
| Q41916852 | Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease |
| Q39278084 | Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study |
| Q41945144 | Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients |
| Q36309457 | Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla |
| Q43417859 | Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. |
| Q41913288 | Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation |
| Q41919391 | Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. |
| Q38009852 | Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus |
| Q39031764 | Hydroxychloroquine in systemic lupus erythematosus (SLE). |
| Q37854742 | Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy |
| Q41336601 | Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling |
| Q39144641 | Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study |
| Q46643929 | Hydroxychloroquine: the cornerstone of lupus therapy |
| Q41917416 | Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study |
| Q38557048 | Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics |
| Q34098294 | Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus |
| Q37258447 | Scavenging nucleic acid debris to combat autoimmunity and infectious disease |
| Q41944686 | The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters |
| Q37947108 | The role of antimalarial agents in the treatment of SLE and lupus nephritis |
| Q37552947 | Therapeutic options for rheumatoid arthritis |
| Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
| Q84600129 | [Antimalarials: an update in rheumatic diseases] |
| Q36919722 | p38 MAPK signaling in oral-related diseases |
Search more.